A 39-year-old woman underwent intralesional sclerotherapy with a single dose of bleomycin [ dose not stated ] for a vascular malformation of the posterior tongue. She developed nonpruritic, painless, flagellate hyperpigmentation on her trunk within 1 week following treatment. The hyperpigmentation ...
Bleomycin sclerotherapy for bilateral pneu- mothoraces in a patient with AIDS. Ann Intern Med 1990; 113: 988–90. Warts. A number of studies have examined the local use of ble- omycin sulfate to treat severe or resistant warts (p.1584) of the common, plane, plantar, eponychial, and ...
These lesions are best managed by sclerotherapy due to their posterior location and risk of bleeding if surgery surgery is attempted. Many sclerosants have been used for treating palatal vascular malformations but the use of intralesional bleomycin for these lesions has not been reported at length....
14 patients had received prior treatments including surgery, laser therapy, or non-bleomycin sclerotherapy. With an average three sessions of bleomycin sclerotherapy (average total dose 34.5mg), more than 80% shrinkage was observed in seven patients (38.9%), 50鈥 80% shrinkage in eight patients ...
The present report documents 6 patients who developed distinctive hyperpigmented skin lesions after bleomycin sclerotherapy for vascular malformations of the face, neck, and extremities. The patients ranged in age from 2 to 65 years and included both black and white and male and female patients. ...
Bleomycin was used for sclerotherapy in all the cases with a maximum dose per session of treatment limited to 15 mgs. Direct Puncture Sclerotherapy Technique OLMs target was determined using pre-procedure MR imaging and direct puncture either per-cutaneous or per-conjunctival was achieved using ...
In our present study, we used bleomycin for intralesional sclerotherapy for cystic hygromas of head neck region, as an alternative to surgical excision. We also statistically analyzed the pattern of cystic hygroma in head and neck region. Our present study was a prospective observational study of...
sclerotherapyLymphatic malformations (LMs) are rare congenital anomalies. The traditional treatment is surgical excision, but intralesional sclerosing agent injection is also preferred as the first-choice treatment because of postoperative frequent recurrences, poor cosmetic results, and high complication rate...
Results A total of 21 studies (including 428 cases) about bleomycin sclerotherapy for LMs were included in the current meta-analyses. We calculated pooled effective rate and 95% Confidence Interval (95% CI) using random effects model to evaluate the relations between bleomycin and LMs. The ...
SclerotherapyStabilityVenous malformationObjective: This study investigated the in vitro stability of a novel sclerosant, bleomycin polidocanol foam (BPF), for venous malformation (VM) sclerotherapy. Methods: The study was designed with control groups treated with polidocanol (0.5%, 1%, and 3%) only...